Inhaled Nitric Oxide CA4028v4

Preview

download Inhaled Nitric Oxide CA4028v4
Download

Overview

To ensure that inhaled nitric oxide iNO is used in a safe effective appropriate and cost-effective way for term or near term infants >34 weeks gestation with hypoxic respiratory failure associated with PPHN on the neonatal unit.

Categories
Clinical
Reference
Date Uploaded
29.08.2017
Date Review
29.08.2020
File Size
563Kb


Clinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.